Sinusitis is generally first treated with antibiotics, decongestants and/or anti-inflammatory drugs. If medication is not effective, or if there is a blockage, surgery is generally recommended. Your ENT specialist will prescribe medications (antibiotics, decongestants, nasal steroid sprays, antihistamines) and procedures (flushing) for treating acute sinusitis.
The most common corrective surgery approach for treatment of acute or chronic sinus inflammation is endocscopic sinus surgery or navigated sinus surgery, or a combination of both. Both techniques are much less invasive than older conventional surgical methods. Nevertheless, the extent of sinus disease varies from person to person. Surgery may therefore be a relatively minimal procedure or an extensive and prolonged operation.
The sinuses are physically close to the brain, the eye, and major arteries, always areas of concern when a fiber optic tube is inserted into the sinus region. The growing use of a new technology, image-guided endoscopic surgery, is alleviating that concern. This type of surgery may be recommended for severe forms of chronic sinusitis, in cases when previous sinus surgery has altered anatomical landmarks, or where a patient's sinus anatomy is very unusual, making typical surgery difficult. Image-guidance is a near-three-dimensional mapping system that combines computed tomography (CT) scans and real-time information about the exact position of surgical instruments using infrared signals. In this way, surgeons can navigate their surgical instruments through complex sinus passages and provide surgical relief more precisely.
Balloon Sinuplasty™ technology is a FDA-cleared, endoscopic, catheter-based system for patients suffering from sinusitis. The technology uses a small, flexible, Sinus Balloon Catheter to open up blocked sinus passageways, restoring normal sinus drainage and function. When the sinus balloon is inflated, it gently restructures and widens the walls of the passageway while maintaining the integrity of the sinus lining.
Dr. Zimm now provides PROPEL™ the first of a new category of products offering localized, controlled drug delivery directly to the sinus tissue. Inserted by Dr. Zimm to maintain the surgical opening, the spring-like implant expands to prop open the ethmoid sinus and gradually delivers an advanced corticosteroid with anti-inflammatory properties directly to the sinus lining where it's needed most as the implant dissolves.